Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with

R Davis Holmes1, Irene M Vavasour1, Jamie Greenfield2

  • 1Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

Insights

Diffusely abnormal white matter (DAWM) is common in clinically isolated syndrome (CIS) and increases the risk of conversion to multiple sclerosis (MS). This finding suggests DAWM is an early indicator of MS progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Diffusely abnormal white matter (DAWM) is a nonlesional MRI finding in approximately 25% of multiple sclerosis (MS) patients.
  • DAWM has not been previously studied in patients with clinically isolated syndrome (CIS), an earlier stage of MS.

Purpose of the Study:

  • Determine the prevalence of DAWM in CIS patients suggestive of MS.
  • Assess the association between DAWM and demographic, clinical, and MRI characteristics.
  • Evaluate the prognostic value of DAWM for conversion from CIS to MS.

Main Methods:

  • 142 CIS participants were classified into DAWM and non-DAWM groups.
  • Participants were followed for up to 24 months or until MS diagnosis.
  • Conversion to MS (2005 McDonald criteria) within 6 months was the primary outcome.

Main Results:

  • DAWM was identified in 27.5% of CIS participants.
  • DAWM correlated with brainstem symptom onset, corticosteroid treatment, dissemination in space, and T2 lesion volume.
  • DAWM significantly increased the risk of conversion to MS within 6 months (HR=2.24, p=0.004), even after adjusting for high-risk imaging features (HR=1.68, p=0.10).

Conclusions:

  • DAWM occurs in a similar proportion of patients with CIS and clinically definite MS.
  • DAWM is associated with an elevated risk of conversion to MS within 6 months in CIS patients.